Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06047028 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

StatusRecruiting
PhaseNot specified
Started2023-07-01
View on ClinicalTrials.gov ↗
Heart failure due to coronary artery disease represents a significant cause of mortality. The detection of patients eligible for bypass surgery is a pivotal concern. Nevertheless, the optimal approach for patient selection based on conventional imaging scans remains unclear. The proposed method (Hyperpolarized 13C MRI) has gained extensive use in evaluating in vivo metabolism. This method avoids ionizing radiation and provides critical insights into cardiac function. The feasibility study aims to investigate this method for patient selection before bypass surgery. This innovative imaging technique facilitates the identification of two simple molecules, bicarbonate and lactic acid, produced at high rates by normal heart metabolism. Both bicarbonate and lactate originate from the same precursor molecule, pyruvate. The data generated from this study holds the potential to refine diagnostic precision.

Amendment history 2 changes detected by DataLookout

2026-09-12
critical
Primary completion pushed: 2026-06-30 → 2027-06-30
2026-09-12
minor
Completion pushed: 2026-06-30 → 2027-06-30
Trial Details
NCT Number NCT06047028
Lead Sponsor University of Texas Southwestern Medical Center
Collaborators: American Heart Association
Conditions Coronary Artery Disease, Ischemic Heart Disease (IHD), Myocardial Viability
Enrollment 30 participants
Start Date 2023-07-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-11